Lucentis

Lucentis (Ranibizumab) is an intravitreal injection used to treat eye conditions. This medication is designed to address specific retinal disorders, offering targeted therapy for improved vision.

Lucentis is primarily used for the treatment of wet age-related macular degeneration (AMD), a condition that can lead to vision loss. It is also used for diabetic macular edema and other retinal disorders. The medication works by inhibiting vascular endothelial growth factor (VEGF), which can help reduce abnormal blood vessel growth in the retina.

Common effects of Lucentis may include temporary vision disturbances, eye redness, and floaters. Some patients may experience increased eye pressure or inflammation. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Lucentis should be administered by a healthcare professional experienced in intravitreal injections. Patients should inform their doctor about any existing eye infections or conditions. Proper hygiene and sterile techniques are crucial to minimize the risk of infection.

Lucentis may interact with other medications, particularly those that affect the immune system or blood vessels. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with Lucentis, so it's important to follow medical advice.